Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.

Non Interventional Study in Slovak Patients With Primary Open Angle Glaucoma and/or Ocular Hypertension Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy Due to Ineffectivity or Intolerance.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00801437

Enrollment

457

Registered

2008-12-03

Start date

2008-10-31

Completion date

2009-06-30

Last updated

2021-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Open-angle

Keywords

glaucoma, open-angle, non-interventional study, safety, tolerability

Brief summary

This study is designed to evaluate the safety and tolerability of Xalacom in patients with primary glaucoma

Detailed description

according to physicians decision, patients who met inclusion and exclusion criteria and sign the ICD

Interventions

DRUGXalacom

Xalacom 1 drop into the affected eye daily

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 99 Years

Healthy volunteers

Inclusion criteria

* primary open angle glaucoma * ocular hypertension * age \>18 years

Exclusion criteria

* bradycardia * obstructive pulmonary disease * hypersensitivity to the drug

Design outcomes

Primary

Measure	Time frame
Incidence of ocular hyperemia	12 months
safety of treatment	12 months

Secondary

Measure	Time frame
effectiveness in IOP lowering	12 months

Countries

Slovakia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026